Profile
Mr. John Ruesch is a Chief Technical Operations Officer at BioCryst Pharmaceuticals, Inc. Mr. Ruesch was previously employed as a SVP-Pharmaceutical Sciences & Technical Operations by Astria Therapeutics, Inc., a Vice President-Pharmaceutical Development by Surface Oncology, Inc., and a Senior Director-Drug Product Development by Biogen, Inc. He received his undergraduate degree from Valparaiso University and an MBA from Kellogg School of Management.
John Ruesch active positions
| Companies | Position | Start |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 22/01/2026 |
Former positions of John Ruesch
| Companies | Position | End |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2024 |
| SURFACE ONCOLOGY, INC. | Corporate Officer/Principal | 31/12/2022 |
| BIOGEN INC. | Corporate Officer/Principal | 30/11/2021 |
Training of John Ruesch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Astria Therapeutics, Inc.
Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Valparaiso University
Valparaiso University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Surface Oncology, Inc.
Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
- Stock Market
- Insiders
- John Ruesch
















